Article

New ACR Recommendations on Rheumatoid Arthritis Assessment: Why and How

Measuring rheumatoid arthritis symptoms is the focus of new American College of Rheumatology guidelines. An ACR panel member tells how they help assess RA.

(AUDIO) The American College of Rheumatology has issued new recommendations for measuring symptoms and outcomes in rheumatoid arthritis. The six endorsed measures are: The Clinical Disease Activity Index, the Disease Activity Score with 28-joint counts (erythrocyte sedimentation rate or C-reactive protein), the Patient Activity Scale (PAS), PAS-II, the Routine Assessment of Patient Index Data with 3 measures, and the Simplified Disease Activity Index.

Listen as Dr. Salahuddin Kazi, a lead researcher with the guidelines committee, tells why the committee chose these six sets of assessment measures, and how they will help you in managing the condition. Dr. Kazi is Chief Informatics officer and associate professor of medicine in the division of rheumatology at the VA North Texas Healthcare System in Dallas.

The questions:

♦  What mandated guidelines for new measurement standards in RA?
♦  Why six sets of measures? Why not one or two?
♦  How much time will this add to a patient visit? What will be the impact on practice efficiency?
♦  Where can doctors find the recommended measures for rheumatoid arthritis assessment?
♦  What are the remaining areas of uncertainty?

 

ACR's New Recommendations on Rheumatoid Arthritis Assessment: Why and How

 

References:

Standard RA Disease Activity Measures Endorsed by ACRMusculoskeletal Network, April 2, 2012

Rheumatoid Arthritis Disease Activity Measures: American College of Rheumatology Recommendations for Use in Clinical PracticeAmerican College of Rheumatology website

Measure CalculatorsAmerican College of Rheumatology website

Related Videos
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Leonard H. Calabrese, DO, Professor of Medicine and Vice Chair, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Alvin Wells, MD, PhD: Making Informed Treatment Decisions With New Testing Strategies
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
© 2024 MJH Life Sciences

All rights reserved.